Antibiotic-resistant gram-positive cocci: Implications for surgical practice

World Journal of Surgery

Volumn 22, Issue 2, 1998, Pages 118-126

  Barie, Philip S ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; ANTIBIOTIC AGENT; BACITRACIN; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; GENTAMICIN; MACROLIDE; METICILLIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; APLASTIC ANEMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BONE MARROW TOXICITY; DRUG CHOICE; ENTEROCOCCUS; FACE MASK; GRAM POSITIVE COCCI; HAND WASHING; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HUMAN; INDWELLING CATHETER; INFECTION CONTROL; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; REVIEW; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL GLOVE; SURGICAL INFECTION; TOPICAL DRUG ADMINISTRATION;

CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

EID: 0031933210     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900359     Document Type: Review

References (55)

1. Barie, P.S.: Emerging problems in gram-positive infections in the postoperative patient. Surg. Gynecol. Obstet. 177:S55, 1993
2. Jarvis, W.R.: Nosocomial outbreaks: the Centers for Disease Control's hospital infections program experience. Am. J. Med. 91(Suppl. 3B):101, 1991
3. Davis, J.M., Huycke, M.M., Wells, C.L., Bohnen, J.M., Gadaleta, D., Fichtl, R.E., Barie, P.S.: Surgical Infection Society position on vancomycin-resistant Enterococcus. Arch. Surg. 131:1061, 1996
4. Kedzia, W., Kukula, H., Gosiinska, O.: The emergence of methicillin-vancomycin resistant staphylococci in Polish hospitals [abstract]. Presented at the Seventh International Congress for Infectious Diseases, Hong Kong, June 1996
5. Hospital Infection Control Practices Advisory Committee (HICPAC): Recommendations for preventing the spread of vancomycin resistance. Infect. Control Hosp. Epidemiol. 16:105, 1995
6. Duffull, S.B., Chambers, S.T., Begg, E.J.: How vancomycin is used in Australasia - a survey. Aust. N.Z.J. Med. 23:662, 1993
7. Mulligan, M.E., Murray-Leisure, K.A., Ribner, B.S., Standiford, H.C., John, J.F., Korvick, J.A., Kauffman, C.A., Yu, V.L.: Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am. J. Med. 94:313, 1993
8. Hartman, B.J., Tomasz, A.: Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 29:85, 1986
9. Hurlimann-Dalel, R.L., Ryffel, C., Kayser, F.H., Berger-Bachi, B.: Survey of the methicillin resistance-associated genes mecA, mecR1-mecl, and femA-femB in clinical isolates of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2617, 1992
10. Doebbeling, B.N.: The epidemiology of methicillin-resistant Staphylococcus aureus: colonization and infection. J. Chemother. 7(Suppl. 3):99, 1995
11. Perdreau-Remington, F., Stefanik, D., Peters, G., Ruckdeschel, G., Haas, F., Wenzel, R., Pulverer, G.: Methicillin-resistant Staphylococcus haemolyticus on the hands of health care workers: a route of transmission or a source? J. Hosp. Infect. 31:195, 1995
12. Phillips, L.G., Heggers, J.P., Robson, M.C.: Burn and trauma units as sources of methicillin-resistant Staphylococcus aureus. J. Burn Care Rehabil. 13:293, 1992
13. Boyce, J.M.: Strategies for controlling methicillin-resistant Staphylococcus aureus in hospitals. J. Chemother. 7(Suppl. 3):81, 1995
14. Hartstein, A.I., Denny, M.A., Morthland, V.H., Le Monte, A.M., Pfaller, M.A.: Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit. Infect. Control Hosp. Epidemiol. 16:405, 1995
15. Hill, R.L.R., Duckworth, G.J., Casewell, M.W.: Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus iwith mupirocin during a hospital outbreak. J. Antimicrob. Chemother. 22:177, 1988
16. Pujol, M., Pena, C., Pallares, R., Ariza, J., Arats, J., Dominguez, M.A., Gudiol, F.: Nosocomial Staphylococcus aureus: bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am. J. Med. 100:509, 1996
17. Carroll, D.J., Austin, G.E., Stajich, G.V., Miyahara, R.K., Murphy, J.E., Ward, E.S.: Effect of education on the appropriateness of serum drug concentration determination. Ther. Drug Monit. 14:81, 1992
18. Freeman, C.D., Quintiliani, R., Nightingale, C.H.: Vancomycin therapeutic drug monitoring: is it necessary? Ann. Pharmacother. 27:594, 1993
19. Khatib, R., Riederer, K.M., Held, M., Aljundi, H.: Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy. Scand. J. Infect. Dis. 27:529, 1995
20. Coronado, V.G., Edwards, J.R., Culver, D.H., Gaynes, R.P.: Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in the United States: National Nosocomial Infections Surveillance (NNIS) System. Infect. Control Hosp. Epidemiol. 16:71, 1995
21. Harrington, G.D., Zarins, L.T., Ramsay, M.A., Bradley, S.F., Kauffman, C.A.: Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin. Diagn. Microbiol. Infect. Dis. 21:27, 1995
22. Mainardi, J.L., Shlaes, D.M., Goering, R.V., Shlaes, J.H., Acar, J.F., Goldstein, F.W.: Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis. 171:1646, 1995
23. Kloos, W.E., Bannerman, T.L.: Update on clinical significance of coagulase-negative staphylococci. Clin. Microbiol. Rev. 7:117, 1994
24. Quie, P.G., Belani, K.K.: Coagulase-negative staphylococcal adherence and persistence. J. Infect. Dis. 156:543, 1987
25. Archer, G.L.: Molecular epidemiology of multiresistant Staphylococcus epidermidis. J. Antimicrob. Chemother. 21(Suppl.):133, 1988
26. Koitalinen, P., Nikoskelainen, J., Huovinen, P.: Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J. Infect. Dis. 161:41, 1990
27. Froggatt, J.W., Johnston, J.L., Galetto, D.W., Archer, G.L.: Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 33:460, 1989
28. Bullard, K.L., Dunn, D.L.: Diagnosis and treatment of bacteremia and intravascular catheter infections. Am. J. Surg. 172(Suppl. 6A):13S, 1996
29. Calderwood, S.B., Swinski, L.A., Waternaux, C.M., Karchmer, A.W., Buckley, M.J.: Risk factors for the development of prosthetic valve endocarditis. Circulation 72:31, 1985
30. Mayhall, C.G., Archer, N.H., Lamb, A., Spadora, A.C., Baggett, J.W., Ward, J.D., Narayan, R.K.: Ventriculostomy-related infections: a prospective epidemiologic study. N. Engl. J. Med. 310:553, 1984
31. Luer, M.S., Hatton, J.: Vancomycin administration into the cerebrospinal fluid: a review. Ann. Pharmacother. 27:912, 1993
32. Slight, P.H., Gundling, K., Plotkin, S.A., Schut, L., Bruce, D., Sutton, L.: A trial of vancomycin for prophylaxis of infections after neurosurgical shunts [letter]. N. Engl. J. Med. 312:921, 1985
33. Barie, P.S., Christou, N.V., Dellinger, E.P., Rout, R.R., Stone, H.H.: Pathogenicity of the enterococcus in surgical infections. Ann. Surg. 212:155, 1990
34. Horodniceanu, T., Bougueleret, L., El-Solh, N., Bieth, G., Delbos, F.: High-level, plasmin-borne resistance to gentamicin in Streptococcus fecalis subsp. zymogenes. Antimicrob. Agents Chemother. 16:686, 1977
35. Arthur, M., Courvalin, P.: Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37:1563, 1993
36. Noble, W.C., Virani. Z., Cree, R.G.A.: Co-transfer of vancomycin and other resistance genes, from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEBS Microbiol. Lett. 93:195, 1992
37. Leclercq, R., Derlot, E., Duval, J., Courvalin, P.: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157, 1988
38. Uttley, A.H.C., Collins, C.H., Naidoo, J., George, R.C.: Vancomycin-resistant enterococci. Lancet 1:57, 1988
39. Frieden, T.R., Munsiff, S.S., Low, D.E., Willey, B.M., Williams, G., Faur, Y., Eisner, W., Warren, S., Kreiswirth, B.: Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76, 1993
40. Centers for Disease Control and Prevention: Nosocomial enterococci resistant to vancomycin: United States, 1989-1993. M.M.W.R. 42:597, 1993
41. Jordens, J.Z., Bates, J., Griffiths, D.T.: Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 34:515, 1994
42. Edmond, M.B., Ober, J.F., Weinbaum, D.L., Pfaller, M.A., Hwang, T., Sanford, M.D., Wenzel, R.P.: Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis. 20:1126, 1995
43. Torres, C., Reguera, J.A., Sanmartin, M.J., Perez-Diaz, J.C., Baquero, F.: VanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J. Antimicrob. Chemother. 33:553, 1994
44. Jones, W.G., Barie, P.S., Yurt, R.W., Goodwin, C.W.: Enterococcal burn sepsis: a highly lethal complication in severely burned patients. Arch. Surg. 121:649, 1986
45. Jones, W.G., Barie, P.S.: Enterococcal infections in surgical patients. Infect. Surg. 7:733, 1988
46. Maki, D.G., Agger, W.A.: Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine 67:248, 1988
47. Norris, A.H., Reilly, J.P., Edelstein, P.H., Brennan, P.J., Schuster, M.G.: Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clin. Infect. Dis. 20:1137, 1995
48. Jernigan, J.A., Titus, M.G., Groschel, D.H., Getchell-White, S., Farr, B.M.: Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am. J. Epidemiol. 143: 496, 1996
49. Rumbak, M.J., Cancio, M.R.: Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention protocol. Crit. Care Med. 23:1200, 1995
50. Murray, B.E.: Editorial response: what can we do about vancomycin-resistant enterococci? Clin. Infect. Dis. 20:1134, 1995
51. Goldmann, D., Larson, E.: Hand-washing and nosocomial infections. N. Engl. J. Med. 327:120, 1992
52. Quale, J., Landman, D., Saurina, G., Atwood, E., Di Tore, V., Patel, K.: Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin. Infect. Dis. 23: 120, 1996
53. Reduced susceptibility of Staphylococcus aureus to vancomycin -Japan, 1996. M.M.W.R. Morb. Mortal. Wkly. Rep. 46:624, 1997
54. Michel, M., Gutmann, L.: Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Therapeutic realities and possibilities. Lancet 349:1901, 1997
55. Dever, L.L., Smith S.M., DeJesus, D.: Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): A report of 15 cases. Microbiol. Drug Resist. 2:401, 1996